Navigation Links
Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop

the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com. All session times listed are Eastern European Daylight Time.

CONTACT: Jennifer Snyder (media), +1-617-444-1439, or Kyle Kuvalanka(investors), +1-857-498-0818

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html /

Ticker Symbol: (NASDAQ-NMS:MLNM)

Terms and conditions of use apply
Copyright ©
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:7/14/2014)... -- The legalization of medical and recreational marijuana is ... new economic driver – that has taken legislators by ... response to the will of the people about a ... a National Press Club Newsmakers news conference on Thursday, ... the area of marijuana legalization will discuss its far-reaching ...
(Date:7/14/2014)... 2014 Decision Resources Group finds that ... perceptions of emerging drugs for both oncologists and ... (50 medical oncologists and 50 hematological oncologists) and ... care organizations (MCOs), reveals that despite lower familiarity ... of payers say this designation will likely influence ...
(Date:7/14/2014)... HAMILTON, N.J. , July 14, 2014 /PRNewswire/ ... Group, LLC is pleased to announce that its ... the Association for the Assessment and Accreditation of ... humane treatment of animals in science worldwide through ... highest standards for animal care and use in ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2
... Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the ... leading academic institutions using CyberKnife radiosurgery in breast cancer ... Southwestern and Fox Chase Cancer Center, will be presented ... for Radiation Oncology (ASTRO) in San Diego from October ...
... 30 Researchers from the University of Bari, Italy, ... creates a sustained viral response (SVR) and protects them ... to determine the long-term clinical outcomes of patients posttransplant ... (HCV) infection of the liver graft. ...
Cached Medicine Technology:CyberKnife Radiosurgery for Early-Stage Breast Cancer 2CyberKnife Radiosurgery for Early-Stage Breast Cancer 3CyberKnife Radiosurgery for Early-Stage Breast Cancer 4CyberKnife Radiosurgery for Early-Stage Breast Cancer 5CyberKnife Radiosurgery for Early-Stage Breast Cancer 6Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes 2
(Date:7/14/2014)... Wisconsin (PRWEB) July 14, 2014 Secure ... software security, is partnering with the Software Assurance Marketplace ... to improve the software that drives everyday life. , ... institutions and housed in the Morgridge Institute for Research, ... S&T to advance software security practices by building a ...
(Date:7/14/2014)... 13, 2014 (HealthDay News) -- Along with improving vision, ... Alzheimer,s disease and other types of dementia, a new ... of life, the researchers said. "These preliminary results ... benefits for people with dementia and their loved ones, ... Case Western Reserve University and University Hospitals Case Medical ...
(Date:7/14/2014)... 2014 (HealthDay News) -- Being physically active in middle ... disease and other types of dementia, suggest the findings ... found that physical exercise at various levels, especially in ... from the Mayo Clinic, said in an Alzheimer,s Association ... are not yet conclusive. More research is needed to ...
(Date:7/14/2014)... By Amy Norton ... -- Older adults who enjoy mentally stimulating games may have ... research suggests. The study looked at the connection between ... mental acuity for adults in their 50s and 60s. ... every other day performed better on tests of memory and ...
(Date:7/14/2014)... KeyPoint Credit Union is teaming up ... run and one-mile family fun walk. The run begins ... and finishes inside Levi’s® Stadium. , Over the past ... the Mission City Community Fund. All proceeds benefit education, ... Seasoned athletes, part-time pavement-pounders and walkers are invited to ...
Breaking Medicine News(10 mins):Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Staying Active May Help Prevent Dementia 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3
... for patient ... care, ... Sutter Health hospitals currently in,bargaining have voted overwhelmingly to authorize a strike ... Nurses Organizing Committee announced today. There has,been no progress in bargaining over ...
... for humans, it offered immunity for at least 6 months ... anthrax vaccine proved highly effective in tests in mice and ... , After it was placed inside the animals, noses, the ... survived after they received injections of 1,000 times the lethal ...
... AMCS ),a leader in radiology and medical image and information ... the,Thomas Weisel Partners Healthcare Conference 2007 being held in Boston. ... -- Thursday, September 6, 2007 ... a.m. (Eastern Time), ...
... Cleveland-based The ScottCare,Corporation, a leader in ... telemetry, announced today that,the company has completed ... Rozinn Electronics, Inc., a privately-held market leader ... "We are very pleased to welcome ...
... BlueShield of South,Carolina has created a new division ... Davis to vice president in charge of the ... CEO M. Edward Sellers and is,responsible for enhancing ... a corporate-wide executive development program. "We are ...
... the September issue of The American Naturalist, Juan Carranza ... Javier Prez-Barber a (Macaulay Institute, United Kingdom) offer a ... to intense competition are born with lower survival expectancies ... smaller molars relative to their body size and ...
Cached Medicine News:Health News:Nurses Send Sutter a Clear Message 2Health News:Nurses Send Sutter a Clear Message 3Health News:AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007 2Health News:The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products 2Health News:S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President 2
... InterStim Therapy for Urinary Control offers ... retention and the symptoms of overactive ... significant symptoms of urgency-frequency alone or ... failed or could not tolerate more ...
... 4 Conti is a battery operated dual-channel therapy ... conditions described below. ELPHA 4 Conti also includes ... and faecal incontinence ELPHA 4 Conti provokes a ... user can feel which muscles need exercising. In ...
... Template Set is the HDR solution which ... technique. The template set consists of a ... sutured to the patient and is placed ... Grid Face Plates. The Stepper Holder is ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
Medicine Products: